These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22438097

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Eun JR, Lee HJ, Moon HJ, Kim TN, Kim JW, Chang JC.
    Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.
    Kim BK, Park JY, Choi HJ, Kim DY, Ahn SH, Kim JK, Lee DY, Lee KH, Han KH.
    J Cancer Res Clin Oncol; 2011 Apr; 137(4):659-67. PubMed ID: 20552225
    [Abstract] [Full Text] [Related]

  • 30. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification.
    Miyaki D, Aikata H, Honda Y, Naeshiro N, Nakahara T, Tanaka M, Nagaoki Y, Kawaoka T, Takaki S, Waki K, Hiramatsu A, Takahashi S, Ishikawa M, Kakizawa H, Awai K, Chayama K.
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1850-7. PubMed ID: 23020312
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. 5-Fluorouracil and alpha-interferon in hepatocellular carcinoma.
    Stuart K, Tessitore J, Huberman M.
    Am J Clin Oncol; 1996 Apr; 19(2):136-9. PubMed ID: 8610636
    [Abstract] [Full Text] [Related]

  • 37. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.
    Rosen I, Kori M, Eshach Adiv O, Yerushalmi B, Zion N, Shaoul R.
    World J Gastroenterol; 2013 Feb 21; 19(7):1098-103. PubMed ID: 23467199
    [Abstract] [Full Text] [Related]

  • 38. Factors predicting response and survival in 149 patients with unresectable hepatocellular carcinoma treated by combination cisplatin, interferon-alpha, doxorubicin and 5-fluorouracil chemotherapy.
    Leung TW, Tang AM, Zee B, Yu SC, Lai PB, Lau WY, Johnson PJ.
    Cancer; 2002 Jan 15; 94(2):421-7. PubMed ID: 11905412
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.